GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss
BMD testing should be based on risk factors like age, sex, prior fractures, and clinical judgment
Late last month, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said in a statement that the FDA decision was not necessarily the end of the story, adding that he was not persuaded that the regulator had the data necessary to truly determine whether the shortage had ended
Here are the most common errors and how to avoid them
Missing doses or stopping the medication regularly can also reduce effectiveness
The extent of direct blood-brain barrier penetration varies by agent